Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: A Pragmatic Multicentre Randomised Placebo Controlled Trial — David Price (2018) | RDL Network
Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: A Pragmatic Multicentre Randomised Placebo Controlled Trial
Article 2018 en
Authors
DP
David Price
SC
Seonaidh Cotton
SF
Shona Fielding
Abstract
1 min read
This abstract is funded by: National Institute for Health Research Health Technology Assessment Presented at mini symposium: B14. LATE BREAKING CLINICAL TRIALS AND FIRST REPORTS IN ASTHMA AND COPD Monday 21st May 2018
Graham Devereux, Seonaidh Cotton, Peter J Barnes, Andrew Briggs, Graham Burns, Rekha Chaudhuri, Henry Chrystyn, Lisa Davies, Anthony De Soyza, Shona Fielding, Simon Gompertz, John Haughney, Amanda Lee, Kirsty McCormack, Gladys McPherson, Alyn H. Morice, John Norrie, A. Sullivan, Andrew M. Wilson, David Price
Graham Devereux, Seonaidh Cotton, Shona Fielding, Nicola McMeekin, Peter J Barnes, Andrew Briggs, Graham Burns, Rekha Chaudhuri, Henry Chrystyn, Lisa Davies, Anthony De Soyza, Simon Gompertz, John Haughney, Karen Innes, Joanna Kaniewska, Amanda Lee, Alyn H. Morice, John Norrie, A. Sullivan, Andrew M. Wilson, David Price
Trishul Siddharthan, Suzanne L. Pollard, Peter Jackson, Nicole Robertson, Adaeze C. Wosu, Nihaal Rahman, Roma Padalkar, Isaac Sekitoleko, Esther Namazzi, Patricia Alupo, John R. Hurst, Robert Kalyesubula, David W. Dowdy, Robert A. Wise, Peter J Barnes, William Checkley, Bruce Kirenga
Trishul Siddharthan, Suzanne L. Pollard, Peter Jackson, Nicole Robertson, Adaeze C. Wosu, Nihaal Rahman, Roma Padalkar, Isaac Sekitoleko, Esther Namazzi, Patricia Alupo, John R. Hurst, Robert Kalyesubula, David W. Dowdy, Robert A. Wise, Peter J Barnes, William Checkley, Bruce Kirenga
Discussion(0)
No comments yet. Be the first to comment.